Amplitude Titration to Improve ECT Clinical Outcomes

Abroad (travel likely)Recruiting

Conditions

Depression · ECT · Cognitive Change

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of New Mexico Health Science Center, Albuquerque, New Mexico, United States
Contact: Study coordinator (Chris Abbott, MD) · cabbott@salud.unm.edu · 505-272-2223

Study leads

Chris Abbott, MD
Principal Investigator
University of New Mexico

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy

Electroconvulsive Therapy · Major Depressive Disorder · Magnetic Seizure Therapy

Abroad (travel likely)Recruiting

Hefei, China

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

Depression · Major Depressive Disorder · Major Depression

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

DBS for Depression

Treatment Resistant Depression

Abroad (travel likely)RecruitingPHASE1

Queens, United States

Psilocybin Therapy for Depression in Parkinson's Disease

Parkinson Disease · Depression

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States